{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:43:56Z","timestamp":1782726236505,"version":"3.54.5"},"reference-count":49,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"International Respiratory Coalition.","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,1,23]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Our systematic evidence map aimed to identify lung-related epidemiological estimates to populate the International Respiratory Coalition's Lung Facts website. We highlight important evidence gaps, suggest how they could be filled, and provide bespoke societal cost estimates to inform resource allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined 14 lung conditions across 53 World Health Organization Europe countries, seeking incidence, prevalence, mortality, years of life lost, years lived with disability, and disability-adjusted life year (DALY) estimates by age\/sex. Global Burden of Disease (GBD) study estimates were obtained for nine GBD-included lung conditions: asthma, COPD, interstitial lung disease and pulmonary sarcoidosis, lower respiratory infections, lung cancer\/tracheal, bronchus and lung cancer, tuberculosis, mesothelioma, COVID-19 and pulmonary arterial hypertension. Systematic searches of bibliographic databases were necessary for five non-GBD-included lung conditions: cystic fibrosis, obstructive sleep apnoea (OSA), influenza, alpha-1 antitrypsin deficiency (A1AD) and bronchiectasis. All-age country-specific DALY estimates were multiplied by gross domestic product per capita as a proxy for a country's wealth and prosperity to estimate societal costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Complete data for nine lung conditions for all countries were extracted from GBD, enabling societal cost estimation. Significant gaps were found for A1AD (only prevalence for 24 countries) and bronchiectasis (incidence, prevalence and mortality for between one and five countries), with more, but incomplete, estimates for cystic fibrosis, OSA and influenza.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>More epidemiological evidence is required for A1AD, bronchiectasis, cystic fibrosis, OSA, and influenza. Inclusion in the GDB study could help address these gaps. Lung Facts provides comprehensive lung-related epidemiological and societal cost estimates covering 53 countries to support policy-makers advocating for respiratory interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.01351-2025","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:50:17Z","timestamp":1775130617000},"page":"01351-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The epidemiological burden and societal cost of 14 respiratory conditions in the World Health Organization European region: systematic evidence map and economic analysis"],"prefix":"10.1183","volume":"12","author":[{"given":"Sue","family":"Harnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-2994","authenticated-orcid":false,"given":"Joan B.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthea","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-4586","authenticated-orcid":false,"given":"Judith","family":"Garcia-Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-8332","authenticated-orcid":false,"given":"Pippa","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3149-9444","authenticated-orcid":false,"given":"Guy","family":"Joos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2026062901451813000_12.3.01351-2025.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00367-2"},{"key":"2026062901451813000_12.3.01351-2025.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00107803"},{"key":"2026062901451813000_12.3.01351-2025.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105513"},{"key":"2026062901451813000_12.3.01351-2025.4","unstructured":"Global Burden of Disease Collaboratative Network . Global Burden of Disease (GBD). Date last accessed: 5 March 2025. www.healthdata.org\/research-analysis\/gbd"},{"key":"2026062901451813000_12.3.01351-2025.5","unstructured":"Global Burden of Disease Collaborators . GBD Results. Date last accessed: 5 March 2025. https:\/\/vizhub.healthdata.org\/gbd-results\/"},{"key":"2026062901451813000_12.3.01351-2025.6","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0215-7"},{"key":"2026062901451813000_12.3.01351-2025.7","unstructured":"Tan-Torres Edejer T , Baltussen R , Adam T , et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva, World Health Organization, 2003."},{"key":"2026062901451813000_12.3.01351-2025.8","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0162-x"},{"key":"2026062901451813000_12.3.01351-2025.9","unstructured":"World Health Organization (WHO) . Macroeconomics and Health: Investing in Health for Economic Development: Report of the Commission on Macroeconomics and Health. Geneva, WHO, 2001."},{"key":"2026062901451813000_12.3.01351-2025.10","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czw096"},{"key":"2026062901451813000_12.3.01351-2025.11","unstructured":"Fernando J . Gross Domestic Product (GDP): Formula and How to Use It. Investopedia. Date last accessed: 14 November 2023. Date last updated: 9 March 2026. www.investopedia.com\/terms\/g\/gdp.asp"},{"key":"2026062901451813000_12.3.01351-2025.12","first-page":"673","article-title":"Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE","volume":"10","author":"Bertram","year":"2021","journal-title":"Int J Health Policy Manag"},{"key":"2026062901451813000_12.3.01351-2025.13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40258-023-00802-y","article-title":"How much should be invested in lung care across the WHO European region? Applying a monetary value to disability-adjusted life-years within the International Respiratory Coalition's Lung Facts","volume":"21","author":"Franklin","year":"2023","journal-title":"Appl Health Econ Health Policy"},{"key":"2026062901451813000_12.3.01351-2025.14","unstructured":"World Health Organization (WHO) . Global Health Expenditure Database 2021. Date last accessed: 28 January 2025. https:\/\/apps.who.int\/nha\/database\/Select\/Indicators\/en"},{"key":"2026062901451813000_12.3.01351-2025.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.01.009"},{"key":"2026062901451813000_12.3.01351-2025.16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/genes11060589","article-title":"The changing epidemiology of cystic fibrosis: incidence, survival and impact of the CFTR gene discovery","volume":"11","author":"Scotet","year":"2020","journal-title":"Genes"},{"key":"2026062901451813000_12.3.01351-2025.17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026062901451813000_12.3.01351-2025.18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","article-title":"Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017","volume":"7","author":"Troeger","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2026062901451813000_12.3.01351-2025.19","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S125389"},{"key":"2026062901451813000_12.3.01351-2025.20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12890-020-1050-0","article-title":"Prevalence and incidence of bronchiectasis in Italy","volume":"20","author":"Aliberti","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2026062901451813000_12.3.01351-2025.21","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212514"},{"key":"2026062901451813000_12.3.01351-2025.22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.13075\/ijomeh.1896.00667","article-title":"Spatial and temporal variability of bronchiectasis cases in Silesian voivodeship in 2006\u20132010","volume":"29","author":"Niewiadomska","year":"2016","journal-title":"Int J Occup Med Environ Health"},{"key":"2026062901451813000_12.3.01351-2025.23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01033-2015"},{"key":"2026062901451813000_12.3.01351-2025.24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00499-2019"},{"key":"2026062901451813000_12.3.01351-2025.25","doi-asserted-by":"crossref","first-page":"e0162282","DOI":"10.1371\/journal.pone.0162282","article-title":"Time trends in hospital admissions for bronchiectasis: analysis of the Spanish national hospital discharge data (2004 to 2013)","volume":"11","author":"S\u00e1nchez-Mu\u00f1oz","year":"2016","journal-title":"PLoS One"},{"key":"2026062901451813000_12.3.01351-2025.26","unstructured":"NHS Digital . National Audit of Pulmonary Hypertension Great Britain, 2020\u201321. 20th January 2022. https:\/\/files.digital.nhs.uk\/75\/83A559\/NAPH%2012AR%20-%20Main%20Report%20v1.1.pdf"},{"key":"2026062901451813000_12.3.01351-2025.27","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0121-2016"},{"key":"2026062901451813000_12.3.01351-2025.28","doi-asserted-by":"crossref","first-page":"e12038","DOI":"10.1002\/pul2.12038","article-title":"Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic","volume":"12","author":"Jansa","year":"2022","journal-title":"Pulm Circ"},{"key":"2026062901451813000_12.3.01351-2025.29","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020977300"},{"key":"2026062901451813000_12.3.01351-2025.30","doi-asserted-by":"crossref","first-page":"e0130072","DOI":"10.1371\/journal.pone.0130072","article-title":"Prevalence of pulmonary hypertension in the general population: the Rotterdam Study","volume":"10","author":"Moreira","year":"2015","journal-title":"PLoS One"},{"key":"2026062901451813000_12.3.01351-2025.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001281"},{"key":"2026062901451813000_12.3.01351-2025.32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000538293","article-title":"Genetic epidemiology of alpha-1 antitrypsin deficiency in Macaronesia","volume":"103","author":"Blanco","year":"2024","journal-title":"Respiration"},{"key":"2026062901451813000_12.3.01351-2025.33","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-023-02810-7"},{"key":"2026062901451813000_12.3.01351-2025.34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.medcli.2023.06.006","article-title":"Cystic fibrosis: epidemiology, clinical manifestations, diagnosis and treatment","volume":"161","author":"Diab C\u00e1ceres","year":"2023","journal-title":"Med Clin"},{"key":"2026062901451813000_12.3.01351-2025.35","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/ppul.27019","article-title":"Cystic fibrosis in Iceland and the high prevalence of the N1303K variant","volume":"59","author":"Elidottir","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"2026062901451813000_12.3.01351-2025.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jopan.2023.01.018"},{"key":"2026062901451813000_12.3.01351-2025.37","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12925"},{"key":"2026062901451813000_12.3.01351-2025.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101871"},{"key":"2026062901451813000_12.3.01351-2025.39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12985-023-02238-1","article-title":"Epidemiology of influenza over a ten-year period in Belgium: overview of the historical and current evidence","volume":"20","author":"Prezzi","year":"2023","journal-title":"Virol J"},{"key":"2026062901451813000_12.3.01351-2025.40","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/jcm13051386","article-title":"Prevalence of obstructive sleep apnea in the young adult population: a systematic review","volume":"13","author":"Zasadzi\u0144ska-Stempniak","year":"2024","journal-title":"J Clin Med"},{"key":"2026062901451813000_12.3.01351-2025.41","doi-asserted-by":"publisher","DOI":"10.1177\/1753465812457113"},{"key":"2026062901451813000_12.3.01351-2025.42","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1080\/15412555.2017.1286166","article-title":"Alpha-1-antitrypsin deficiency: disease management and learning from studies","volume":"14","author":"Greulich","year":"2017","journal-title":"COPD"},{"key":"2026062901451813000_12.3.01351-2025.43","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01166-2023"},{"key":"2026062901451813000_12.3.01351-2025.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00685-8"},{"key":"2026062901451813000_12.3.01351-2025.45","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1093\/ije\/dyad146","article-title":"Cohort profile: Burden of Obstructive Lung Disease (BOLD) study","volume":"52","author":"Amaral","year":"2023","journal-title":"Int J Epidemiol"},{"key":"2026062901451813000_12.3.01351-2025.46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5588\/ijtld.24.0331","article-title":"Asthma and allergies in schoolchildren: data from the European SINPHONIE study","volume":"29","author":"Sarno","year":"2025","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026062901451813000_12.3.01351-2025.47","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12020315"},{"key":"2026062901451813000_12.3.01351-2025.48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/hec.2925","article-title":"Priority setting in global health: towards a minimum DALY value","volume":"23","author":"Drake","year":"2014","journal-title":"Health Econ"},{"key":"2026062901451813000_12.3.01351-2025.49","unstructured":"Zhang K , Garau M . International cost-effectiveness thresholds and modifiers for HTA decision making. London, Office of Health Economics, 2020."}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01351-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:46Z","timestamp":1782722746000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01351-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1183\/23120541.01351-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01351-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}